BRISTOL-MYERS SQUIBB COMPANY Operating Lease, Weighted Average Discount Rate, Percent
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Operating Lease, Weighted Average Discount Rate, Percent of 5.00% as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-11
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 4.00%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 4.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 5.00% 10-K · filed 2026-02-11 |
| 2024-12-31 | 5.00% 10-K · filed 2026-02-11 |
| 2023-12-31 | 4.00% 10-K · filed 2025-02-12 |
| 2022-12-31 | 4.00% 10-K · filed 2024-02-13 |
| 2021-12-31 | 3.00% 10-K · filed 2023-02-14 |
| 2020-12-31 | 3.00% 10-K · filed 2022-02-09 |
| 2019-12-31 | 4.00% 10-K · filed 2021-02-10 |
| 2019-09-30 | 4.00% 10-Q · filed 2019-10-31 |
| 2019-06-30 | 4.00% 10-Q · filed 2019-07-25 |
| 2019-03-31 | 4.00% 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |